MDS Virtual Congress 2021 Archives - Page 94 of 132

Post-Traumatic Stress Disorder and risk of Parkinson’s Disease– 20 Years Follow-up real world data analysis

Y. Barer, G. Chodick, T. Gurevich (Tel Aviv, Israel)
Potential drug-drug interactions in hospitalized patients with Parkinson’s disease from tertiary center in Serbia

D. Aleksic, S. Stefanovic, M. Milosavljevic, J. Milosavljevic, S. Jankovic (Kragujevac, Serbia)
Prasinezumab reduced progression of Parkinson’s disease motor features measured by Roche PD Mobile Application v2 sensor features: PASADENA Phase II Part 1

K. Taylor, F. Lipsmeier, E. Volkova-Volkmar, D. Rukina, J. Anzures Cabrera, L. Essioux, M. Abt, B. van Lier, A. Thomann, H. Svoboda, W. Zago, R. Postuma, G. Pagano, M. Lindemann (Basel, Switzerland)
Precision Medicine in Neurodegeneration associated with Pantothenate kinase (PKAN) , its possible?

J. Abril Jaramillo (Seville, Spain)
Predicting MDS-UPDRS Ratings for Deep Brain Stimulation Patients Using Wearable Sensor Data

J. Watts, A. Khojandi, M. Niethammer, R. Ramdhani (Knoxville, USA)
Predictive factors of LCIG infusion therapy adherence – a single-center study of 103 consecutive LCIG patients

V. Viljaharju, T. Mertsalmi, KAM. Pauls, M. Koivu, J. Eerola-Rautio, M. Udd, E. Pekkonen (Helsinki, Finland)
Predictive value of UPSIT subsets in prodromal Parkinson disease

P. Vaswani, J. Morley, D. Jennings, A. Siderowf, K. Marek, P. Investigators (Philadelphia, USA)
Predictors of antidepressant and benzodiazepine treatment in Parkinson’s disease

G. Gentile, G. Zanotelli, L. Weis, R. Biundo, F. Sambataro, A. Antonini (Padua, Italy)
Predictors of Clinically Significant Quality of Life Impairment in Parkinson´s Disease. Results from the COPPADIS Cohort at 2 Years Follow-up.

D. Santos García, C. Cores, T. de Deus, J. Paz González, C. Martínez, E. Suárez, S. Jesús, M. Aguilar, P. Pastor, LL. Planellas, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, M. Catalán, V. Nogueira, V. Puente, M. de Arcos, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, E. Erro, J. Kulisevsky, M. Blázquez, M. Seijo, J. Ruíz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González, C. Ordás, L. López Díaz, P. Mir, P. Martínez Martín (A Coruña, Spain)
Predictors of Persistence to Deutetrabenazine Among Patients With Tardive Dyskinesia (TD) and Huntington’s Disease (HD)

D. Claassen, R. Ayyagari, V. Garcia-Horton, S. Zhang, S. Leo (Nashville, USA)